Using a measure of the hormone N-terminal brain natriuretic peptide (BNP) to guide therapy for older patients with heart failure did not improve overall clinical or quality of life outcomes compared ...

B-type natriuretic peptide (BNP) as well as its N-terminal fragment (NT-proBNP) can provide useful diagnostic and prognostic information in patients with acute dyspnea and chronic heart failure.

First results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) show that testing for brain natriuretic peptide (BNP) when evaluating congestive heart failure (CHF) patients ...

BNP Paribas Easy JPM ESG EMBI Global Diversified Composite UCITS ETF - CHF hedged: Actualités, news et informations ETF BNP Paribas Easy JPM ESG EMBI Global Diversified Composite UCITS ETF - CHF hedge ...

BNP Paribas Funds SMaRT Food Privilege H 574 M EUR -3,33 %-2,69 % BNP Paribas Funds SMaRT Food Classic H E 574 M EUR -4,41 %-5,85 % BNP PARI SMART FOO 683 M USD -6,62 % +0,40 % BNP PARI SMART FOO 520 ...

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

BACKGROUND: The use of brain natriuretic peptide (BNP) in the evaluation of the dyspneic pediatric patient is increasingly supported for infants and newborns with congenital heart disease. However, ...

Diastolic heart failure is common in the elderly, particularly women. Previous studies on the value of brain natriuretic peptide in diastolic dysfunction have been largely limited to male subjects.